| 4.4 |
17.6 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 3.3 |
9.9 |
GO:0090194 |
negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
| 3.1 |
9.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 3.0 |
8.9 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 2.7 |
13.4 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 2.4 |
7.3 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 2.4 |
7.1 |
GO:0060437 |
lung growth(GO:0060437) |
| 2.2 |
6.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 2.1 |
4.3 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 2.1 |
12.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 2.0 |
6.0 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 1.8 |
5.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 1.7 |
8.7 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.7 |
5.1 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 1.7 |
10.2 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 1.7 |
6.8 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 1.7 |
5.0 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.7 |
5.0 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.6 |
23.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 1.6 |
4.8 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.6 |
4.7 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 1.5 |
6.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 1.5 |
4.5 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.5 |
13.3 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.5 |
1.5 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 1.5 |
4.4 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 1.4 |
4.3 |
GO:1904706 |
response to cisplatin(GO:0072718) negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 1.4 |
7.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.4 |
8.3 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 1.4 |
4.1 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.3 |
13.4 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.3 |
3.8 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 1.3 |
1.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 1.2 |
8.7 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 1.2 |
3.6 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 1.2 |
5.8 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 1.1 |
5.7 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 1.1 |
4.5 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 1.1 |
4.5 |
GO:0060266 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 1.1 |
10.0 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 1.1 |
5.5 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 1.1 |
7.6 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.1 |
4.3 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 1.1 |
8.5 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 1.1 |
2.1 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.0 |
3.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 |
3.0 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.0 |
4.0 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.0 |
7.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 1.0 |
5.0 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 1.0 |
4.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.0 |
2.9 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.9 |
6.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.9 |
3.7 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.9 |
2.8 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.9 |
5.3 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.9 |
2.6 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.9 |
1.7 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.9 |
2.6 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) regulation of vascular wound healing(GO:0061043) glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.8 |
3.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.8 |
5.1 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.8 |
2.5 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.8 |
4.9 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.8 |
8.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.8 |
2.4 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.8 |
1.6 |
GO:1905065 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.8 |
1.6 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.8 |
2.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.8 |
7.0 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.8 |
3.8 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.8 |
3.0 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.8 |
3.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.8 |
2.3 |
GO:1903599 |
aggrephagy(GO:0035973) positive regulation of mitophagy(GO:1903599) |
| 0.8 |
3.0 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.8 |
3.0 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
| 0.7 |
1.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.7 |
1.5 |
GO:2000974 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.7 |
2.9 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.7 |
3.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.7 |
5.7 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.7 |
7.0 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.7 |
2.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.7 |
4.1 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.7 |
2.0 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
2.7 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.7 |
2.0 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.7 |
1.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.7 |
8.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.7 |
7.2 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.7 |
4.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.6 |
1.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.6 |
1.9 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.6 |
0.6 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.6 |
3.8 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.6 |
1.9 |
GO:0032847 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of cellular pH reduction(GO:0032847) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.6 |
9.3 |
GO:1904816 |
positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.6 |
1.8 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.6 |
1.2 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.6 |
2.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 |
1.7 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.6 |
2.8 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.6 |
2.8 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.5 |
3.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.5 |
1.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 |
1.1 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.5 |
0.5 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.5 |
2.7 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.5 |
2.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.5 |
2.7 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.5 |
3.7 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.5 |
1.6 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 |
2.6 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.5 |
1.0 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.5 |
1.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.5 |
2.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.5 |
1.6 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.5 |
2.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
1.5 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 |
1.5 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.5 |
0.5 |
GO:0046655 |
folic acid metabolic process(GO:0046655) |
| 0.5 |
3.5 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.5 |
5.0 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.5 |
1.0 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.5 |
11.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.5 |
2.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.5 |
2.9 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.5 |
5.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.5 |
2.8 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.5 |
0.5 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.5 |
1.9 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.5 |
1.8 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.5 |
3.2 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.5 |
1.8 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.4 |
1.8 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.4 |
1.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 0.4 |
1.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 |
1.7 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.4 |
1.7 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
0.9 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.4 |
2.5 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.4 |
2.1 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
8.8 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.4 |
1.2 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.4 |
2.1 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.4 |
1.6 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.4 |
9.2 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.4 |
1.6 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
16.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.4 |
3.9 |
GO:0061032 |
positive regulation of platelet activation(GO:0010572) folic acid transport(GO:0015884) visceral serous pericardium development(GO:0061032) |
| 0.4 |
9.0 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.4 |
0.8 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 0.4 |
0.8 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.4 |
4.6 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.4 |
3.4 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) genitalia morphogenesis(GO:0035112) |
| 0.4 |
0.4 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.4 |
3.0 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
0.7 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.4 |
1.1 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
1.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.4 |
3.3 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.4 |
2.6 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.4 |
5.4 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.4 |
3.9 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.4 |
1.8 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.4 |
1.1 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.4 |
0.7 |
GO:0046084 |
adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
| 0.3 |
2.1 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 |
1.7 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 |
1.4 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 |
1.0 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
2.4 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.3 |
1.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.3 |
8.7 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.3 |
1.3 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.3 |
3.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
3.0 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.3 |
5.3 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.3 |
11.2 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
6.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.3 |
0.6 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.3 |
3.2 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.3 |
0.6 |
GO:0072053 |
trachea cartilage morphogenesis(GO:0060535) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.3 |
2.8 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
4.0 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 |
1.5 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.3 |
0.6 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.3 |
1.8 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
1.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.3 |
1.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 |
0.9 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.3 |
0.9 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.3 |
1.1 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.3 |
0.6 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.3 |
0.8 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
1.6 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.3 |
7.2 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.3 |
0.8 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.3 |
2.9 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
1.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 |
6.6 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.3 |
3.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
0.8 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.3 |
1.9 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.3 |
1.1 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 |
0.8 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.3 |
0.8 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.3 |
4.7 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.3 |
2.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
4.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.3 |
3.1 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.3 |
3.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
2.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
2.0 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.2 |
1.5 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.2 |
0.7 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.2 |
0.2 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 |
3.1 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.2 |
0.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
1.2 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.2 |
10.1 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.2 |
1.4 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
1.8 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.2 |
2.7 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
1.1 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.2 |
2.0 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.2 |
4.5 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.2 |
1.3 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.2 |
0.7 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
5.9 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
0.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.2 |
0.7 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 |
0.6 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
1.3 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.6 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) regulation of potassium ion export(GO:1902302) |
| 0.2 |
0.9 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.2 |
0.4 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.2 |
0.4 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
1.7 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.2 |
2.7 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.2 |
2.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 |
0.8 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.2 |
2.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
1.4 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.2 |
0.6 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
1.6 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.2 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
2.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
17.1 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.2 |
0.6 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.2 |
0.8 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.2 |
2.9 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.2 |
2.1 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.2 |
0.8 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
0.4 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.2 |
7.0 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.6 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) regulation of corticosterone secretion(GO:2000852) |
| 0.2 |
0.9 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.2 |
1.9 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.2 |
5.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
1.8 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 |
0.9 |
GO:0046040 |
IMP metabolic process(GO:0046040) |
| 0.2 |
0.9 |
GO:1902861 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) copper ion import into cell(GO:1902861) |
| 0.2 |
2.3 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.2 |
2.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
1.4 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 |
0.5 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 |
0.7 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.3 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 |
0.3 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.2 |
0.7 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.2 |
0.5 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
4.8 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
0.3 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 |
10.3 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.2 |
3.2 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.2 |
0.5 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.2 |
0.2 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.2 |
3.2 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 |
0.7 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.2 |
1.0 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 |
0.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
1.5 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 |
1.0 |
GO:0034123 |
positive regulation of toll-like receptor signaling pathway(GO:0034123) |
| 0.2 |
0.5 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
6.3 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.2 |
0.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.8 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.2 |
3.7 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.2 |
1.8 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.2 |
0.6 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
2.1 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.6 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
4.1 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
1.6 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
5.2 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
1.7 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
0.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.3 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.1 |
0.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
2.2 |
GO:0043567 |
positive regulation of activated T cell proliferation(GO:0042104) regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.5 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
3.7 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.1 |
2.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.7 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.1 |
3.8 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
2.7 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
7.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.1 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
3.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
2.1 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.5 |
GO:0046684 |
response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.1 |
0.9 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
0.2 |
GO:0019919 |
peptidyl-arginine modification(GO:0018195) peptidyl-arginine methylation(GO:0018216) peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.7 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 |
1.6 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.5 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
5.4 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
2.5 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 |
0.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.2 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
2.4 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.6 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.1 |
0.7 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.8 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.1 |
1.5 |
GO:0031050 |
dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
| 0.1 |
0.7 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
0.7 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
0.4 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
0.6 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.1 |
0.9 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
4.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.5 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
3.7 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
3.2 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.2 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.1 |
4.6 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
2.8 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
1.0 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
3.3 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
1.6 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.6 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
3.2 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.1 |
2.6 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
3.3 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.5 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
2.4 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.1 |
0.2 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.1 |
0.6 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
3.5 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 |
1.3 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
1.2 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.9 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 |
0.4 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.1 |
4.8 |
GO:1904591 |
positive regulation of protein import(GO:1904591) |
| 0.1 |
2.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.9 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.1 |
0.7 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
2.0 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
1.5 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
0.5 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.9 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
0.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
1.5 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.3 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.1 |
0.5 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.2 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.6 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.4 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.9 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 |
0.2 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
1.0 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.1 |
0.7 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
2.7 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.2 |
GO:0090342 |
regulation of cell aging(GO:0090342) regulation of cellular senescence(GO:2000772) |
| 0.1 |
1.0 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.7 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.1 |
0.3 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.1 |
0.3 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.1 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.1 |
1.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.5 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.1 |
0.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
5.2 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.1 |
0.3 |
GO:0090220 |
telomere localization(GO:0034397) meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.1 |
1.1 |
GO:2000648 |
positive regulation of stem cell proliferation(GO:2000648) |
| 0.1 |
0.5 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.1 |
1.4 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
3.9 |
GO:0051453 |
regulation of intracellular pH(GO:0051453) |
| 0.1 |
1.0 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
1.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.1 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 |
0.5 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 0.1 |
0.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
1.1 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
6.7 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.1 |
0.3 |
GO:0060665 |
mesenchymal-epithelial cell signaling(GO:0060638) regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.5 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 |
0.6 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.9 |
GO:0046321 |
positive regulation of fatty acid oxidation(GO:0046321) |
| 0.1 |
0.4 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
2.7 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.1 |
0.7 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
1.5 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.7 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.4 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 |
0.6 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.5 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.1 |
0.6 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.1 |
0.9 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
5.9 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.1 |
0.2 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
3.4 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.1 |
0.2 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.1 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
2.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.3 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.1 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
3.9 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
1.0 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
0.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.4 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
1.9 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.9 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 0.0 |
0.8 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.0 |
0.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.6 |
GO:0007007 |
inner mitochondrial membrane organization(GO:0007007) |
| 0.0 |
0.2 |
GO:0035372 |
protein localization to microtubule(GO:0035372) regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.0 |
1.8 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.7 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.0 |
0.5 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.1 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.2 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.5 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.0 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.8 |
GO:0034644 |
cellular response to UV(GO:0034644) |
| 0.0 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.7 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
1.9 |
GO:0030177 |
positive regulation of Wnt signaling pathway(GO:0030177) |
| 0.0 |
0.5 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.0 |
0.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:1902566 |
regulation of eosinophil activation(GO:1902566) |
| 0.0 |
0.2 |
GO:0010717 |
regulation of epithelial to mesenchymal transition(GO:0010717) |
| 0.0 |
0.5 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.4 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.2 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 |
0.2 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.4 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
1.7 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.2 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.0 |
0.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.0 |
0.3 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.1 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.0 |
0.1 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.3 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.6 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.5 |
GO:0042773 |
ATP synthesis coupled electron transport(GO:0042773) |
| 0.0 |
0.7 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
1.1 |
GO:0030326 |
embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
| 0.0 |
0.4 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.4 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.1 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.0 |
0.0 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.9 |
GO:0006457 |
protein folding(GO:0006457) |
| 0.0 |
0.3 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.0 |
1.1 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
0.1 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.0 |
0.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.0 |
GO:0015791 |
polyol transport(GO:0015791) |
